Management of hyperglycemia from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeting T790M-mediated resistance

Lignende værker

• Is T790M mutation the key in development of resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)?
  af: Takabe, Kazuaki
  Udgivet: (2011)
• Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities
  af: Villadolid, Jeryl, et al.
  Udgivet: (2015)
• Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)
  af: Mountzios, Giannis
  Udgivet: (2018)
• Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs
  af: Ma, Li, et al.
  Udgivet: (2021)
• Efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in targeted therapy of lung squamous cell carcinoma patients with EGFR mutation: a pooled analysis
  af: Zhuang, Jingqi, et al.
  Udgivet: (2017)